Trademark: 97913008
Word
ROSLINCT
Status
Pending
Status Code
686
Status Date
Tuesday, May 14, 2024
Serial Number
97913008
Mark Type
4
Filing Date
Friday, April 28, 2023
Published for Opposition
Tuesday, May 14, 2024

Trademark Owner History
Roslin Cell Therapies Limited - Owner At Publication

Classifications
41 Education and training services, namely, classes, seminars, tutorials, conferences and workshops in the fields of cell therapy and gene therapy; provision of online education, training and teaching services, namely, classes, non-downloadable webinars and tutorials in the fields of cell therapy and gene therapy; arranging, organising and conducting of colloquiums, conferences, congresses, seminars and symposiums in the fields of cell therapy and gene therapy; publication of books, scientific papers and texts in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
40 Contract manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; contract manufacturing in the fields of cell therapy and gene therapy; custom manufacturing of pharmaceutical and biopharmaceutical products in the fields of cell therapy and gene therapy; custom manufacturing in the fields of cell therapy and gene therapy; custom fabrication and production of cells for others; manufacturing process consulting in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
9 Scientific apparatus and instruments, namely, bioreactors for cell culturing, laboratory incubators and laboratory centrifuges for use in the development, testing, training and, manufacturing of stem cells and related cell and gene therapy products; downloadable computer software and hardware for use in the development, testing, training and, manufacturing of stem cells and related cell and gene therapy products; replacement and structural parts and fittings for the aforesaid goods
16 Paper signs, cardboard signs, and printed matter, namely, brochures, books and journals in the fields of cell therapy and gene therapy; paper instructional and teaching material, except apparatus, in the fields of cell therapy and gene therapy
35 Business information, consultancy and management services in the fields of designing, building, testing and validating processes and systems for use in cell therapy and gene therapy services; business consultation services in the nature of technology transfer advice and management in the fields of cell therapy and gene therapy; advertising, marketing and promotional services in the fields of cell therapy and gene therapy; information, advisory and consultancy services related to the aforesaid
44 Medical services relating to the removal, treatment and processing of stem cells; medical services, namely, stem cell therapy services; medical services, namely, gene therapy services; stem cell bank services, namely, stem cell storage; information, advisory and consultancy services related to the aforesaid
42 Scientific research, development and testing services in the fields of cell therapy and gene therapy; research and development of new products for others in the fields of cell therapy and gene therapy; pharmaceutical and biopharmaceutical research and development services in the fields of cell therapy and gene therapy; scientific consultancy services in the fields of designing, building, testing and validating processes and systems for use in cell therapy and gene therapy services; design and development of computer hardware and software in the biopharmaceutical, cell therapy and gene therapy fields; development of computer databases in the biopharmaceutical, cell therapy and gene therapy fields; scientific development of custom assays for cell therapy and gene therapy; stem cell research services; information, advisory and consultancy services related to the aforesaid
ROSLIN CT

Trademark Events
May 2, 2023
New Application Entered
Jan 25, 2024
Assigned To Examiner
Jan 30, 2024
Non-Final Action Written
Jan 30, 2024
Non-Final Action E-Mailed
Jan 30, 2024
Notification Of Non-Final Action E-Mailed
Apr 2, 2024
Teas/Email Correspondence Entered
Apr 2, 2024
Correspondence Received In Law Office
Apr 2, 2024
Teas Response To Office Action Received
May 27, 2023
New Application Office Supplied Data Entered
Apr 5, 2024
Approved For Pub - Principal Register
Apr 24, 2024
Notification Of Notice Of Publication E-Mailed
May 14, 2024
Published For Opposition
May 14, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24